agilon health (NYSE:AGL) Trading 6.4% Higher – What’s Next?

agilon health, inc. (NYSE:AGL)’s share price shot up 6.4% on Friday . The company traded as high as $2.35 and last traded at $2.33. 281,456 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 2,576,343 shares. The stock had previously closed at $2.19.

Analysts Set New Price Targets

AGL has been the subject of a number of analyst reports. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th. Evercore ISI decreased their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Finally, Barclays lowered their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.98.

agilon health Price Performance

The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of -2.69 and a beta of 0.53. The firm has a 50-day simple moving average of $2.07 and a two-hundred day simple moving average of $3.79. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the company posted ($0.06) EPS. As a group, analysts predict that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction dated Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 90,000 shares of company stock worth $198,100 over the last three months. 3.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC increased its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC increased its position in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Citigroup Inc. boosted its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of agilon health in the 2nd quarter valued at approximately $1,849,000. Finally, Geode Capital Management LLC increased its holdings in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.